REAL-WORLD EVIDENCE OF PREVALENCE OF CARDIOVASCULAR DISEASE AMONGST TREATED DIABETES POPULATION IN 2016

被引：0
|
作者：
Khamis, Z. J. [1 ]
Merali, T. [1 ]
机构：
[1] Drug Intelligence Inc, Toronto, ON, Canada
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 05期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PDB7
引用
收藏
页码：A163 / A163
页数：1
相关论文
共 50 条
  • [41] Editorial: Real-world data and real-world evidence in lung cancer
    Gristina, Valerio
    Eze, Chukwuka
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [42] 20 years of real-world data to estimate chronic kidney disease prevalence and staging in an unselected population
    Santos-Araujo, Carla
    Mendonca, Luis
    Carvalho, Daniel Seabra
    Bernardo, Filipa
    Pardal, Marisa
    Couceiro, Joao
    Martinho, Hugo
    Gavina, Cristina
    Taveira-Gomes, Tiago
    Dinis-Oliveira, Ricardo Jorge
    CLINICAL KIDNEY JOURNAL, 2023, 16 (01) : 111 - 124
  • [43] Editorial: Real-world data and real-world evidence in hematologic malignancies
    Malagola, Michele
    Ohgami, Robert
    Greco, Raffaella
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [44] When can real-world data generate real-world evidence?
    Rahman, Motiur
    Dal Pan, Gerald
    Stein, Peter
    Levenson, Mark
    Kraus, Stefanie
    Chakravarty, Aloka
    Rivera, Donna R.
    Forshee, Richard
    Concato, John
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 (01)
  • [45] Prevalence of Lp(a) in a real-world Portuguese cohort: implications for cardiovascular risk assessment
    Saraiva, Miguel
    Garcez, Jonatas
    da Silva, Beatriz Tavares
    Ferreira, Ines Pocas
    Oliveira, Jose Carlos
    Palma, Isabel
    LIPIDS IN HEALTH AND DISEASE, 2025, 24 (01)
  • [46] Real-world evidence of the risk of neutropenia among patients treated with filgrastim
    Fazio-Eynullayeva, Elnara
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 29 - 29
  • [47] Rates of glycaemic deterioration in a real-world population with type 2 diabetes
    Donnelly, Louise A.
    Zhou, Kaixin
    Doney, Alex S. F.
    Jennison, Chris
    Franks, Paul W.
    Pearson, Ewan R.
    DIABETOLOGIA, 2018, 61 (03) : 607 - 615
  • [48] Rates of glycaemic deterioration in a real-world population with type 2 diabetes
    Louise A. Donnelly
    Kaixin Zhou
    Alex S. F. Doney
    Chris Jennison
    Paul W. Franks
    Ewan R. Pearson
    Diabetologia, 2018, 61 : 607 - 615
  • [49] Real-World Evidence: A Primer
    Amit Dang
    Pharmaceutical Medicine, 2023, 37 : 25 - 36
  • [50] Commentary: Real-world Evidence
    Dadds, Mark R.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF FAMILY THERAPY, 2016, 37 (04) : 465 - 466
12345